NeoVista Company
NeoVista Inc is dedicated to the development of medical technologies that help to advance the treatment of wet age-related macular degeneration (AMD). Wet AMD affects more than 5 million people around the world and is a major cause of blindness in men and women over the age of 50. The unique technology being developed by NeoVista continues to show promise in clinical studies. It is our goal to help improve the quality of care and reduce the burden of this destructive condition on patients, physicians, and the healthcare system.
Investors
Total Funding:
$20M
Headquarters:
Newark, California, United States
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Equity
Technology:
P4 Medicine
Investor Type:
For Profit
Investors Number:
3
Founded Date:
1-1
Industry:
Health Care, Health Diagnostics, Medical Device